Cipla Misses Second-Quarter Profit Estimates as US Sales Are Muted
Cipla’s consolidated net profit fell to ₹878 crore ($92.2 million) in the quarter, as muted Revlimid sales and stiff competition weighed on its US business.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.